Pharmacogenomics, often abbreviated as PGx, is the study of how an individual’s genetic makeup affects their response to drugs. This field combines pharmacology and genomics to guide medication selection and dosing based on genetic variants.

PGx testing helps:

• Reduce adverse drug reactions.
• Improve time to effective therapy.
• Minimize trial and error prescribing.
• Enhance overall treatment efficacy and safety.

Pharmacogenomics enables healthcare providers to personalize treatment by selecting and dosing medications based on a patient’s genetic profile. It is increasingly used across various areas of medicine to improve drug effectiveness, minimize side effects, and prevent adverse drug reactions.

Pharmacogenomics is rapidly advancing in Saudi Arabia as part of Vision 2030’s focus on healthcare innovation, precision medicine, and patient-centered care. National efforts like the Saudi Human Genome Project are paving the way for genomic data in clinical practice, while institutions such as the Genomic Medicine Center at KFSHRC are leading regional implementation.

With the healthcare system shifting toward personalized and preventive care, the growing demand for pharmacogenomics experts is positioning Saudi Arabia as a regional leader in this field.

Barriers include:

• Limited knowledge and training among healthcare providers.
• Insufficient clinical guidelines and reimbursement frameworks.
• Restricted access to tests and genomic data.

• Bachelor’s Degree: Medicine, Pharmacy, Bachelor of Medical Laboratory Science (BMLS)
• Minimum GPA: Good standing bachelor’s degree ( 2/4 or 3/5 )
• English Proficiency: IELTS (Academic): 5.5, TOEFL: 65, STEP: 80
• Letter of Recommendation: One letter of recommendation from academic or professional references.
• Application Fee: A non-refundable application fee: 600 SAR
• Interview: There will be an interview with the program director

• Duration: Two years
• Language: English
• Credits: 43 Credit Hours

The Value Behind the Tuition

This comprehensive program spans two academic years and includes intensive training, access to advanced labs, research guidance, and close mentorship by leading professionals in Saudi Arabia’s medical education landscape.

Alfaisal University provides thesis scholarships up to 50% for thesis programs only.

You need to fulfill the following requirements & conditions:

• Cumulative GPA (3.00 out of 4.00 and above) by the end of the first academic year.
• Full payment of the total tuition fees (100,000 SAR) by the end of the first academic year.

Please note that the scholarship conditions are subject to change without prior notice.

Your study plan includes:

• Biostatistics
• Research Methodology
• Biomedical Ethics
• Introduction to Pharmacogenomics
• Practicum Agenome sequencing
• Fundamentals of Human Genetics and Genomics
• Clinical Pharmacology
• Translational Medicine

This comprehensive Pharmacogenomics track of the Master of Biomedical Sciences program ensures a competitive edge in the Saudi Arabian and international job markets.

Your study plan includes:

• Complete the Online Application Form.
• Submit academic transcripts and recommendation letters.
• Upload a personal statement highlighting your interest in.
• Attend an admissions interview.